CARDIOVASCULAR JOURNAL OF AFRICA • Vol 22, No 3, May/June 2011
154
AFRICA
defects.
Nat Biotechnol
2004;
22
: 560–567.
121. Lendeckel S, Jodicke A, Christophis P, Heidinger K, Wolff J, Fraser
JK,
et al
. Autologous stem cells (adipose) and fibrin glue used to treat
widespread traumatic calvarial defects: case report.
J Craniomaxillofac
Surg
2004;
32
: 370–373.
122. Gimble JM. Adipose tissue-derived therapeutics.
Expert Opin Biol Ther
2003;
3
: 705–713.
123. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H,
et al
.
Cartilage-like gene expression in differentiated human stem cell sphe-
roids: a comparison of bone marrow-derived and adipose tissue-derived
stromal cells.
Arthritis Rheum
2003;
48
: 418–429.
124. Okura H, Matsuyama A, Lee CM, Saga A, Kakuta-Yamamoto A,
Nagao A,
et al
. Cardiomyoblast-like cells differentiated from human
adipose tissue-derived mesenchymal stem cells improve left ventricular
dysfunction and survival in a rat myocardial infarction model.
Tissue
Eng Part C Meth
2010;
16
: 417–425.
125. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H,
et
al
. Monolayered mesenchymal stem cells repair scarred myocardium
after myocardial infarction.
Nat Med
2006;
12
: 459–465.
126. Schenke-Layland K, Strem BM, Jordan MC, Deemedio MT, Hedrick
MH, Roos KP,
et al
. Adipose tissue-derived cells improve cardiac func-
tion following myocardial infarction.
J Surg Res
2009;
153
: 217–223.
127. Valina C, Pinkernell K, Song YH, Bai X, Sadat S, Campeau RJ,
et al
.
Intracoronary administration of autologous adipose tissue-derived stem
cells improves left ventricular function, perfusion, and remodelling
after acute myocardial infarction.
Eur Heart J
2007;
28
: 2667–2677.
128. Ogden CL, Carroll MD, McDowell MA, Flegal KM. Obesity among
adults in the United States – no statistically significant change since
2003-2004.
NCHS Data Brief
2007;
1
: 1–8.
129. Mbanya JCN, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes
in sub-Saharan Africa.
Lancet
2010;
375
: 2254–2266.
130. Mutimura E, Crowther NJ,
Stewart AV, Cade WT. HIV and the cardio-
metabolic syndrome in the developing world: an African perspective.
J
Cardiometab Syndr
2008;
3
: 106–110.
131. Tollman SM, Kahn K, Sartorius B, Collinson MA, Clark SJ, Garenne
ML. Implications of mortality transition for primary health care in rural
South Africa: a population-based surveillance study.
Lancet
2008;
372
:
893–901.
132. Walley AJ, Asher JE, Froguel P. The genetic contribution to non-syndro-
mic human obesity.
Nature Rev Genet
2009;
10
: 431–442.
133. Alvarez-Llamas G, Szalowska E, de Vries MP, Weening D, Landman
K, Hoek A,
et al.
Characterization of the human visceral adipose tissue
secretome.
Mol Cell Proteomics
2007;
6
: 589–600.
134. Hong SJ, Traktuev DO, March KL.
Therapeutic potential of adipose-
derived stem cells in vascular growth and tissue repair.
Curr Opin
Organ Transpl
2010;
15
(1): 86–91.
135. Madonna R, De Caterina R. Adipose tissue: a new source for cardio-
vascular repair.
J Cardiovasc Med (Hagerstown).
2010;
11
(2): 71–80.
136. Cherubino M, Marra KG. Adipose-derived stem cells for soft tissue
reconstruction.
Regen Med
2009;
4
(1): 109–117.
137. De Villiers JA, Houreld N, Abrahamse H. Adipose derived stem cells
and smooth muscle cells: implications for regenerative medicine.
Stem
Cell Rev
2009;
5
(3): 256–265.
138. Taxonera C, Schwartz DA, García-Olmo D. Emerging treatments for
complex perianal fistula in Crohn’s disease.
Wld J Gastroenterol
2009;
15
(34): 4263–4272.
139. Wood L, Juritz J, Havemann J, Lund J, Waldmann H, Hale G, Jacobs P.
Pediatric immunohematopoietic stem cell transplantation at a tertiary
care center in Cape Town.
Hematol Oncol Stem Cell Ther
2008;
1
:
80–89.
Biosketch of André Pascal Kengne, MD, PhD, Internist
Director: MRC National Collaborative Research Programme on Cardiovascular and
Metabolic Disease
Dr Kengne obtained his medical degree from the Faculty of Medicine and Biomedical
Sciences, University of Yaoundé 1, Cameroon and did his residency training in internal
medicine at the Yaoundé University Teaching Hospital. In 2009, he obtained a PhD in
Medicine from the University of Sydney, Australia, with major focus on cardiovascular
epidemiology and prevention.
He is a Fellow of the International Society of Hypertension, the George Institute for
Global Health (Australia) and the Julius Centre for Health Science and Primary Care
(Netherlands), and a member of the American Society of Hypertension, the High Blood
Pressure Council of Australia and other international societies. He is on the editorial
boards of the
Cardiovascular Journal of Africa
and the
Pan-African Medical Journal
,
and serves as reviewer for several other medical journals.
Dr Kengne has authored numerous articles and book chapters in the areas of cardio-
vascular diseases, diabetes and chronic diseases, and clinical decision-making. He has
lectured in Cameroon and elsewhere on various topics in those fields. He has also been
involved in many research projects in Cameroon, Europe and Australia, including the
ADVANCE trial and the Asia Pacific Cohort Studies Collaboration.
He joins the MRC after five consecutive years at the George Institute for Global
Health in Sydney, and a collaborative visit of six months at the Julius Centre for Health
Science and Primary Care in Utrecht, the Netherlands.
